XML 31 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Dec. 31, 2011
Royalty / Mark-up on Cost of Goods Sold / Earn-Out Revenue [Abstract]          
Number of quarters after which revenue is recognized (in quarters)     1    
Number of days after calendar year, after which payments and report are received     90 days    
Accounts Receivable and Allowance for Doubtful Accounts [Abstract]          
Number of major customers     2    
Allowance for doubtful accounts $ 30,095 $ 30,095 $ 30,095 $ 30,095  
Accounts receivable 3,205,394   3,205,394   3,236,917
Reimbursable Third Party Development Costs [Abstract]          
Accrued patent costs 90,000   90,000    
Stock-Based Compensation [Abstract]          
Number of stock-based compensation plans in effect     2    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]          
Stock-based compensation expense 26,400 126,231 202,085 391,138  
Total Number of Shares          
Options Outstanding, beginning of period (in shares)     1,261,425    
Granted (in shares)     15,000    
Forfeited (in shares)     0    
Exercised (in shares)     94,425    
Expired (in shares)     0    
Options Outstanding, end of period (in shares) 1,182,000   1,182,000    
Exercisable, end of period (in shares) 1,102,000   1,102,000    
Weighted Average Exercise Price          
Options Outstanding, beginning of period (in dollars per share)     $ 8.27    
Granted (in dollars per share)     $ 15.75    
Forfeited (in dollars per share)     $ 0    
Exercised (in dollars per share)     $ 1.57    
Expired (in dollars per share)     $ 0    
Options Outstanding, end of period (in dollars per share) $ 8.90   $ 8.90    
Exercisable, end of period (in dollars per share) $ 7.90   $ 7.90    
Proceeds from stock option exercises     148,425 82,450  
Aggregate intrinsic value of options outstanding and exercisable 13,600,000   13,600,000    
Closing price of common stock (in dollars per share) $ 19.42   $ 19.42    
Unrecognized compensation cost related to non-vested stock options outstanding 55,000   55,000    
Weighted-average period over which unrecognized compensation cost to be recognized     6 months    
Minimum [Member]
         
Property, Plant and Equipment [Line Items]          
Estimated useful life of property, plant and equipment     5 years    
Maximum [Member]
         
Property, Plant and Equipment [Line Items]          
Estimated useful life of property, plant and equipment     10 years    
Research and development [Member]
         
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]          
Stock-based compensation expense 13,200 22,138 158,017 74,711  
General and administrative [Member]
         
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]          
Stock-based compensation expense 13,200 104,093 44,068 316,427  
DFB Biotech Inc [Member]
         
Accounts Receivable and Allowance for Doubtful Accounts [Abstract]          
Accounts receivable 100,000   100,000    
Auxilium [Member]
         
Accounts Receivable and Allowance for Doubtful Accounts [Abstract]          
Accounts receivable 100,000   100,000    
Recurring [Member] | Cash and Cash Equivalents [Member]
         
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair Value 3,823,860   3,823,860    
Recurring [Member] | Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]
         
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair Value 3,823,860   3,823,860    
Recurring [Member] | Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 2 [Member]
         
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair Value 0   0    
Recurring [Member] | Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 3 [Member]
         
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair Value 0   0    
Recurring [Member] | Certificates of Deposit [Member]
         
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair Value 5,190,000   5,190,000    
Recurring [Member] | Certificates of Deposit [Member] | Fair Value, Inputs, Level 1 [Member]
         
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair Value 5,190,000   5,190,000    
Recurring [Member] | Certificates of Deposit [Member] | Fair Value, Inputs, Level 2 [Member]
         
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair Value 0   0    
Recurring [Member] | Certificates of Deposit [Member] | Fair Value, Inputs, Level 3 [Member]
         
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair Value $ 0   $ 0